EMBARK, a Phase 3 Trial Evaluating Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Duchenne Muscular Dystrophy (DMD): Study Design and Baseline CharacteristicsFrancesco Muntoni,Eugenio Mercuri, Ulrike Schara Schmidt,Hirofumi Komaki,James Richardson, Tejdip Singh,Maitea Guridi,Stefanie Mason, Alex Murphy,Lixi Yu,Carol Reid, Eddie Darton,Christoph Wandel,Jerry MendellNEUROLOGY（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
